Lexeo Therapeutics Insider Trades
NASDAQ: LXEOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 25 · $867.64K
- Shares bought / sold
- 0 / 155.47K
- Net activity
- Net selling $867,644
Lexeo Therapeutics insider activity
Over the last 12 months, Lexeo Therapeutics insiders reported 42 transactions on SEC Form 4: 0 open-market purchases and 25 sales. Insiders bought $0 and sold $867,644 worth of stock, for net insider selling of $867,644. The largest seller was Townsend Richard Nolan, with $538,240 in reported sales.
The most recent filing shows Bhalla Narinder Pal (Chief Medical Officer) reporting a transaction in 2,714 shares at $3.58 on Sep 14, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put LXEO's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
LXEO insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 14, 2026 | Otero Jose ManuelChief Operating Officer | Award | 2,110 | $5.58K | Form 4 |
| Sep 14, 2026 | Townsend Richard NolanChief Executive Officer | Award | 2,306 | $6.10K | Form 4 |
| Sep 14, 2026 | Bhalla Narinder PalChief Medical Officer | Award | 2,714 | $9.71K | Form 4 |
| Aug 18, 2026 | Otero Jose ManuelChief Operating Officer | Sale | 1,304 | $6.46K | Form 4 |
| Aug 18, 2026 | Tamayo Louis EdwardChief Financial Officer | Sale | 4,117 | $20.20K | Form 4 |
| Aug 18, 2026 | Townsend Richard NolanChief Executive Officer | Sale | 3,345 | $16.56K | Form 4 |
| Jul 1, 2026 | Townsend Richard NolanChief Executive Officer | Sale | 25,947 | $116.24K | Form 4 |
| Jul 1, 2026 | Bhalla Narinder PalChief Medical Officer | Sale | 22,306 | $98.59K | Form 4 |
| Jul 1, 2026 | Otero Jose ManuelChief Operating Officer | Sale | 4,666 | $20.90K | Form 4 |
| Jul 1, 2026 | Tamayo Louis EdwardChief Financial Officer | Sale | 4,641 | $20.84K | Form 4 |
| Jun 29, 2026 | Townsend Richard NolanChief Executive Officer | Award | 67,000 | — | Form 4 |
| Jun 29, 2026 | Bhalla Narinder PalChief Medical Officer | Award | 55,000 | — | Form 4 |
| Jun 29, 2026 | Otero Jose ManuelChief Operating Officer | Award | 12,060 | — | Form 4 |
| Jun 29, 2026 | Tamayo Louis EdwardChief Financial Officer | Award | 12,000 | — | Form 4 |
| May 18, 2026 | Townsend Richard NolanChief Executive Officer | Sale | 3,342 | $16.93K | Form 4 |
| May 18, 2026 | Otero Jose ManuelChief Operating Officer | Sale | 1,302 | $6.61K | Form 4 |
| Apr 6, 2026 | Townsend Richard NolanChief Executive Officer | Sale | 55,000 | $313.14K | Form 4 |
| Mar 13, 2026 | Otero Jose ManuelChief Operating Officer | Award | 5,930 | $15.68K | Form 4 |
| Mar 13, 2026 | Townsend Richard NolanChief Executive Officer | Award | 2,623 | $6.94K | Form 4 |
| Feb 18, 2026 | Townsend Richard NolanChief Executive Officer | Sale | 10,173 | $64.92K | Form 4 |
| Feb 18, 2026 | Otero Jose ManuelChief Operating Officer | Sale | 3,016 | $19.29K | Form 4 |
| Feb 13, 2026 | Bhalla Narinder PalChief Medical Officer | Award | 49,500 | — | Form 4 |
| Feb 4, 2026 | Tamayo Louis EdwardChief Financial Officer | Award | 44,665 | — | Form 4 |
| Feb 4, 2026 | Otero Jose ManuelChief Operating Officer | Award | 65,000 | — | Form 4 |
| Feb 4, 2026 | Townsend Richard NolanChief Executive Officer | Award | 161,665 | — | Form 4 |
| Nov 18, 2025 | Robertson JennyChief Legal Officer | Sale | 549 | $5.09K | Form 4 |
| Nov 18, 2025 | See Tai SandiChief Development Officer | Sale | 386 | $3.58K | Form 4 |
| Nov 18, 2025 | Adler EricChief Medical Officer | Sale | 615 | $5.70K | Form 4 |
| Nov 18, 2025 | Townsend Richard NolanChief Executive Officer | Sale | 1,127 | $10.45K | Form 4 |
| Nov 18, 2025 | Otero Jose ManuelChief Operating Officer | Sale | 721 | $6.68K | Form 4 |
| Oct 17, 2025 | Adler EricChief Medical Officer | Sale | 38 | $363.32 | Form 4 |
| Oct 17, 2025 | Adler EricChief Medical Officer | Sale | 3,344 | $29.88K | Form 4 |
| Oct 17, 2025 | Otero Jose ManuelChief Technical Officer | Sale | 24 | $229.46 | Form 4 |
| Oct 17, 2025 | Otero Jose ManuelChief Technical Officer | Sale | 2,091 | $18.68K | Form 4 |
| Oct 17, 2025 | Robertson JennyChief Legal Officer | Sale | 40 | $382.44 | Form 4 |
| Oct 17, 2025 | Robertson JennyChief Legal Officer | Sale | 3,486 | $31.15K | Form 4 |
| Oct 17, 2025 | See Tai SandiChief Development Officer | Sale | 44 | $420.68 | Form 4 |
| Oct 17, 2025 | See Tai SandiChief Development Officer | Sale | 3,844 | $34.35K | Form 4 |
| Oct 15, 2025 | Adler EricChief Medical Officer | Award | 9,570 | — | Form 4 |
| Oct 15, 2025 | Otero Jose ManuelChief Technical Officer | Award | 5,940 | — | Form 4 |
| Oct 15, 2025 | Robertson JennyChief Legal Officer | Award | 9,900 | — | Form 4 |
| Oct 15, 2025 | See Tai SandiChief Development Officer | Award | 10,890 | — | Form 4 |
| Aug 18, 2025 | Otero Jose ManuelChief Technical Officer | Sale | 721 | $6.68K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4